PINK:NYE-Simplify Exchange Traded Funds - Simplify Health Care ETF (USD)

ETF | Others |

Last Closing

USD 29.605

Change

-0.28 (-0.92)%

Market Cap

USD 0.12B

Volume

0.15M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

N/A

USD 65.72B
JEPI JPMorgan Equity Premium Income..

N/A

USD 33.58B
DFAC Dimensional U.S. Core Equity 2..

N/A

USD 28.01B
DTB DTB

N/A

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

N/A

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 23.40B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 22.11B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 11.37B
DFUV Dimensional US Marketwide Valu..

N/A

USD 10.43B
JAAA Janus Detroit Street Trust - J..

N/A

USD 10.00B

ETFs Containing PINK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.28% 74% C 72% C
Dividend Return 0.11% 5% F 4% F
Total Return 8.39% 73% C 69% C-
Trailing 12 Months  
Capital Gain 18.23% 65% D 66% D+
Dividend Return 1.08% 18% F 12% F
Total Return 19.31% 63% D 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.25% 63% D 48% F
Dividend Return 2.56% 57% F 39% F
Total Return 0.31% 20% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 7.13% 63% D 88% B+
Risk Adjusted Return 35.84% 58% F 57% F
Market Capitalization 0.12B 66% D+ 27% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.